Viemed Healthcare Ownership
| VMD Stock | USD 8.56 0.10 1.15% |
Shares in Circulation | First Issued 2017-03-31 | Previous Quarter 40.6 M | Current Value 40.8 M | Avarage Shares Outstanding 39.9 M | Quarterly Volatility 985.8 K |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Viemed |
Viemed Stock Ownership Analysis
About 13.0% of the company outstanding shares are owned by insiders. The book value of Viemed Healthcare was at this time reported as 3.21. The company had not issued any dividends in recent years. Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana. Viemed Healthcare operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 715 people. For more information please call Casey Hoyt at 337 504 3802 or visit https://www.viemed.com.Besides selling stocks to institutional investors, Viemed Healthcare also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Viemed Healthcare's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Viemed Healthcare's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Viemed Healthcare Quarterly Liabilities And Stockholders Equity |
|
Viemed Healthcare Insider Trades History
About 13.0% of Viemed Healthcare are currently held by insiders. Unlike Viemed Healthcare's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Viemed Healthcare's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Viemed Healthcare's insider trades
Viemed Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Viemed Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Viemed Healthcare backward and forwards among themselves. Viemed Healthcare's institutional investor refers to the entity that pools money to purchase Viemed Healthcare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Awm Investment Company Inc | 2024-09-30 | 612.9 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 539 K | Tocqueville Asset Management L.p. | 2024-09-30 | 417.1 K | Raffles Associates Lp | 2024-09-30 | 402.7 K | Paradigm Capital Management, Inc. | 2024-06-30 | 400 K | Renaissance Technologies Corp | 2024-09-30 | 364.6 K | Divisadero Street Capital Management, Lp | 2024-09-30 | 349.8 K | Cove Street Capital, Llc | 2024-09-30 | 349.2 K | Bard Associates Inc | 2024-09-30 | 345.1 K | Thrivent Financial For Lutherans | 2024-09-30 | 3.4 M | Blackrock Inc | 2024-06-30 | 2.9 M |
Viemed Healthcare Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Viemed Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Viemed Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Viemed Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Viemed Healthcare Outstanding Bonds
Viemed Healthcare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Viemed Healthcare uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Viemed bonds can be classified according to their maturity, which is the date when Viemed Healthcare has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Viemed Healthcare Corporate Filings
F4 | 26th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 14th of November 2024 Other Reports | ViewVerify | |
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 8th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Viemed Healthcare is a strong investment it is important to analyze Viemed Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Viemed Healthcare's future performance. For an informed investment choice regarding Viemed Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viemed Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viemed Healthcare. If investors know Viemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viemed Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.425 | Earnings Share 0.25 | Revenue Per Share 5.534 | Quarterly Revenue Growth 0.174 | Return On Assets 0.0686 |
The market value of Viemed Healthcare is measured differently than its book value, which is the value of Viemed that is recorded on the company's balance sheet. Investors also form their own opinion of Viemed Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Viemed Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viemed Healthcare's market value can be influenced by many factors that don't directly affect Viemed Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viemed Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viemed Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viemed Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.